Nanjing Yingpai Pharmaceutical Co., Ltd.
英派药业
Nanjing Yingpai Pharmaceutical Co., Ltd.
Biotech/Healthcare
Inxity Pharma is dedicated to developing novel targeted cancer therapies with proprietary intellectual property, with a focus on synthetic lethality. Its management team includes executives with many years of drug discovery and development experience at international pharmaceutical companies.
Latest round: Series D Extension+ (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.